ArticlePloS one2025
Comparative effectiveness and safety of insulin reference biologics versus biosimilars for types 1 and 2 diabetes mellitus: Protocol for a systematic review of real-world studies.
Martin K H Ho et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.